{"id":"https://openalex.org/W4379283571","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.3002","title":"First-in-human study of ABBV-011, a seizure-related homolog protein 6 (SEZ6)\u2013targeting antibody-drug conjugate, in patients with small cell lung cancer.","display_name":"First-in-human study of ABBV-011, a seizure-related homolog protein 6 (SEZ6)\u2013targeting antibody-drug conjugate, in patients with small cell lung cancer.","publication_year":2023,"publication_date":"2023-06-01","ids":{"openalex":"https://openalex.org/W4379283571","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.3002"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2023.41.16_suppl.3002","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.3002","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.3002","pdf_url":"https://ascopubs.org/doi/pdf/10.1200/JCO.2023.41.16_suppl.3002?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ascopubs.org/doi/pdf/10.1200/JCO.2023.41.16_suppl.3002?role=tab","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031420337","display_name":"Daniel Morgensztern","orcid":"https://orcid.org/0000-0003-4349-2028","observed_orcids":["https://orcid.org/0000-0003-4349-2028"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Morgensztern","raw_affiliation_strings":["Washington University School of Medicine, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University School of Medicine, St. Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079438136","display_name":"Neal Ready","orcid":"https://orcid.org/0000-0003-4414-9432","observed_orcids":["https://orcid.org/0000-0003-4414-9432"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neal E. Ready","raw_affiliation_strings":["Duke Cancer Institute, Duke University, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Cancer Institute, Duke University, Durham, NC","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4390039326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049294543","display_name":"Melissa Lynne Johnson","orcid":"https://orcid.org/0000-0001-9874-1314","observed_orcids":["https://orcid.org/0000-0001-9874-1314"]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210135086","display_name":"Tennessee Oncology","ror":"https://ror.org/03754ky26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Lynne Johnson","raw_affiliation_strings":["Sarah Cannon Research Institute at Tennessee Oncology, PLLC, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Research Institute at Tennessee Oncology, PLLC, Nashville, TN","institution_ids":["https://openalex.org/I4210100810","https://openalex.org/I4210135086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036587861","display_name":"Afshin Dowlati","orcid":"https://orcid.org/0000-0003-4535-6839","observed_orcids":["https://orcid.org/0000-0003-4535-6839"]},"institutions":[{"id":"https://openalex.org/I4210119077","display_name":"University Hospitals Seidman Cancer Center","ror":"https://ror.org/02kb97560","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210119077"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Afshin Dowlati","raw_affiliation_strings":["University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH","institution_ids":["https://openalex.org/I4210119077","https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025382507","display_name":"Noura J. Choudhury","orcid":"https://orcid.org/0000-0002-5980-4973","observed_orcids":["https://orcid.org/0000-0002-5980-4973"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Noura J. Choudhury","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059652753","display_name":"David Paul Carbone","orcid":"https://orcid.org/0000-0003-3002-1921","observed_orcids":["https://orcid.org/0000-0003-3002-1921"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Paul Carbone","raw_affiliation_strings":["Comprehensive Cancer Center, The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Center, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109504564","display_name":"Eric Scott Schaefer","orcid":"https://orcid.org/0009-0007-4929-6454","observed_orcids":["https://orcid.org/0009-0007-4929-6454"]},"institutions":[{"id":"https://openalex.org/I4210107699","display_name":"Highlands Oncology Group","ror":"https://ror.org/01k1j7593","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210107699"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric S. Schaefer","raw_affiliation_strings":["Highlands Oncology Group, Fayetteville, AR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Highlands Oncology Group, Fayetteville, AR","institution_ids":["https://openalex.org/I4210107699"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030064179","display_name":"Susanne M. Arnold","orcid":"https://orcid.org/0000-0001-6542-9551","observed_orcids":["https://orcid.org/0000-0001-6542-9551"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]},{"id":"https://openalex.org/I2802239656","display_name":"Markey Cancer Center","ror":"https://ror.org/01dhvva97","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285210727","https://openalex.org/I143302722","https://openalex.org/I2802239656"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susanne M. Arnold","raw_affiliation_strings":["University of Kentucky Markey Cancer Center, Lexington, KY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kentucky Markey Cancer Center, Lexington, KY","institution_ids":["https://openalex.org/I143302722","https://openalex.org/I2802239656"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059588535","display_name":"Sonam Puri","orcid":"https://orcid.org/0000-0001-8068-5051","observed_orcids":["https://orcid.org/0000-0001-8068-5051"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sonam Puri","raw_affiliation_strings":["Huntsman Cancer Institute, University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069070706","display_name":"Zofia Piotrowska","orcid":"https://orcid.org/0000-0002-9008-8573","observed_orcids":["https://orcid.org/0000-0002-9008-8573"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zofia Piotrowska","raw_affiliation_strings":["Massachusetts General Hospital, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040118284","display_name":"Aparna Madhukeshwar Hegde","orcid":"https://orcid.org/0000-0001-6616-4882","observed_orcids":["https://orcid.org/0000-0001-6616-4882"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4390039376","display_name":"O'Neal Comprehensive Cancer Center","ror":"https://ror.org/03j18km61","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I4390039250","https://openalex.org/I4390039376"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aparna Madhukeshwar Hegde","raw_affiliation_strings":["O\u2019Neal Comprehensive Cancer Center, University of Alabama, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"O\u2019Neal Comprehensive Cancer Center, University of Alabama, Birmingham, AL","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4390039376"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032284029","display_name":"Anne C. Chiang","orcid":"https://orcid.org/0000-0002-2111-4694","observed_orcids":["https://orcid.org/0000-0002-2111-4694"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anne C. Chiang","raw_affiliation_strings":["Yale School of Medicine, New Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale School of Medicine, New Haven, CT","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018378822","display_name":"Wade Thomas Iams","orcid":"https://orcid.org/0000-0003-2109-298X","observed_orcids":["https://orcid.org/0000-0003-2109-298X"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wade Thomas Iams","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060992997","display_name":"Anthony W. Tolcher","orcid":"https://orcid.org/0000-0002-6322-9721","observed_orcids":["https://orcid.org/0000-0002-6322-9721"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anthony W. Tolcher","raw_affiliation_strings":["NEXT Oncology, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NEXT Oncology, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054118501","display_name":"Kaname Nosaki","orcid":"https://orcid.org/0000-0002-1800-9455","observed_orcids":["https://orcid.org/0000-0002-1800-9455"]},"institutions":[{"id":"https://openalex.org/I4210145079","display_name":"National Cancer Center Hospital East","ror":"https://ror.org/03rm3gk43","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145079"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kaname Nosaki","raw_affiliation_strings":["National Cancer Center Hospital East, Kashiwa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Center Hospital East, Kashiwa, Japan","institution_ids":["https://openalex.org/I4210145079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035048809","display_name":"Jiuhong Zha","orcid":"https://orcid.org/0000-0003-2344-474X","observed_orcids":["https://orcid.org/0000-0003-2344-474X"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jiuhong Zha","raw_affiliation_strings":["AbbVie Inc., North Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, IL","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100448675","display_name":"Rui Li","orcid":"https://orcid.org/0009-0007-2684-1958","observed_orcids":["https://orcid.org/0009-0007-2684-1958"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rui Li","raw_affiliation_strings":["AbbVie Inc., North Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, IL","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056272469","display_name":"Pooja Hingorani","orcid":"https://orcid.org/0000-0002-4772-7456","observed_orcids":["https://orcid.org/0000-0002-4772-7456"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pooja Hingorani","raw_affiliation_strings":["AbbVie Inc., North Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, IL","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001143685","display_name":"Edwin E. Jeng","orcid":"https://orcid.org/0000-0003-2824-4763","observed_orcids":["https://orcid.org/0000-0003-2824-4763"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edwin E. Jeng","raw_affiliation_strings":["AbbVie Inc., North Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, IL","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083477114","display_name":"Muhammad Furqan","orcid":"https://orcid.org/0000-0003-3137-2053","observed_orcids":["https://orcid.org/0000-0003-3137-2053"]},"institutions":[{"id":"https://openalex.org/I4390039339","display_name":"University of Iowa Holden Comprehensive Cancer Center","ror":"https://ror.org/01jhe7086","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I126307644","https://openalex.org/I4390039339"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Muhammad Furqan","raw_affiliation_strings":["Universty of Iowa Holden Comprehensive Cancer Center, Iowa City, IA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universty of Iowa Holden Comprehensive Cancer Center, Iowa City, IA","institution_ids":["https://openalex.org/I4390039339"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":22,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":20,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"41","issue":"16_suppl","first_page":"3002","last_page":"3002"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.008500000461935997,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sez6","display_name":"SEZ6","score":0.9449999928474426},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9599999785423279},{"id":"https://openalex.org/keywords/small-cell-lung-cancer","display_name":"small cell lung cancer","score":0.9549999833106995},{"id":"https://openalex.org/keywords/calicheamicin","display_name":"calicheamicin","score":0.9110000133514404},{"id":"https://openalex.org/keywords/anti-pd-1-combination-therapy","display_name":"anti-PD-1 combination therapy","score":0.6980000138282776},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7110000252723694},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8199999928474426},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7360000014305115},{"id":"https://openalex.org/keywords/tumor-response","display_name":"tumor response","score":0.3630000054836273},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.7110000252723694},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.33500000834465027}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9087845087051392},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.4494679272174835},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4421723484992981},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.4115946590900421},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4112272560596466},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.41029587388038635},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.1646343469619751}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2023.41.16_suppl.3002","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.3002","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.3002","pdf_url":"https://ascopubs.org/doi/pdf/10.1200/JCO.2023.41.16_suppl.3002?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1200/jco.2023.41.16_suppl.3002","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.3002","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.3002","pdf_url":"https://ascopubs.org/doi/pdf/10.1200/JCO.2023.41.16_suppl.3002?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8600000143051147,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4379283571.pdf","grobid_xml":"https://content.openalex.org/works/W4379283571.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4311628015","https://openalex.org/W3191427281","https://openalex.org/W2087016115","https://openalex.org/W2305775430","https://openalex.org/W2783315223","https://openalex.org/W1990197915","https://openalex.org/W2465571689","https://openalex.org/W2427186628","https://openalex.org/W2749516410","https://openalex.org/W2676545322"],"abstract_inverted_index":{"3002":[0],"Background:":[1],"Small":[2],"cell":[3,89],"lung":[4],"cancer":[5],"(SCLC)":[6],"has":[7,47],"a":[8,19,31,43,87,222],"dismal":[9],"prognosis":[10],"and":[11,62,100,102,188,236,278,294,341,375,379,399],"new":[12],"therapies":[13],"are":[14,70],"urgently":[15],"needed.":[16],"SEZ6":[17,41],"is":[18,35,416],"transmembrane":[20],"protein":[21],"expressed":[22],"in":[23,51,83,158,242,262,284],"SCLC":[24,122],"tumors":[25],"that":[26],"may":[27],"be":[28],"used":[29],"as":[30],"therapeutic":[32],"target.":[33],"ABBV-011":[34,68,80,139,174,195,246,400,415],"an":[36,202],"antibody-drug":[37],"conjugate":[38],"(ADC)":[39],"targeting":[40],"with":[42,85,120,173,201,355,407],"calicheamicin":[44],"payload,":[45],"which":[46],"shown":[48],"antitumor":[49,409],"activity":[50,410],"preclinical":[52],"models":[53],"of":[54,65,79,115,125,184,205,212,225,250,301,329,358,360,414],"SCLC.":[55],"Preliminary":[56],"results":[57,238],"from":[58,145],"the":[59,66,98,105,209,243,266,288],"monotherapy":[60],"dose-escalation":[61],"-expansion":[63],"cohorts":[64],"first-in-human":[67],"study":[69,77],"presented.":[71],"Methods:":[72],"Phase":[73],"1,":[74],"open-label,":[75],"multicenter":[76],"(NCT03639194)":[78],"alone":[81],"or":[82,314],"combination":[84],"budigalimab,":[86],"programmed":[88],"death":[90],"1":[91,219,298],"inhibitor.":[92],"Primary":[93],"objectives":[94],"were":[95,128,171,186,198,319],"to":[96,103,147,309,321],"assess":[97],"safety":[99,235],"tolerability":[101],"determine":[104],"maximum":[106],"tolerated":[107,403],"dose":[108,114,210,216],"(MTD)":[109],"and/or":[110],"recommended":[111],"phase":[112],"2":[113],"ABBV-011.":[116,322],"Adults":[117],"(\u226518":[118],"years)":[119],"relapsed/refractory":[121],"(1\u20133":[123],"lines":[124],"prior":[126,193],"therapy)":[127],"enrolled.":[129],"Dose":[130,154],"escalation":[131,217],"was":[132,140,156,178,252,303,324,349,371,384,390,396,401],"guided":[133],"by":[134],"Bayesian":[135],"continual":[136],"reassessment":[137],"method.":[138],"administered":[141],"intravenously":[142],"at":[143,230,404],"doses":[144],"0.3":[146],"2.0":[148,231],"mg/kg":[149,406],"once":[150],"every":[151],"3":[152,228],"weeks.":[153],"expansion":[155],"conducted":[157],"SEZ6-selected":[159],"patients.":[160],"Results:":[161],"At":[162],"data":[163],"cutoff":[164],"on":[165],"August":[166],"22,":[167],"2022,":[168],"99":[169],"patients":[170,185,241,306],"treated":[172],"monotherapy.":[175],"Median":[176,248],"age":[177],"63":[179],"years":[180],"(range,":[181,255],"41\u201379),":[182],"50%":[183],"male,":[187],"68%":[189],"had":[190,221],"received":[191],"\u22652":[192],"therapies.":[194],"ADC":[196],"pharmacokinetics":[197],"approximately":[199],"dose-proportional":[200],"elimination":[203],"half-life":[204],"4.6":[206],"days":[207],"across":[208],"range":[211],"0.3\u20132.0":[213],"mg/kg.":[214,232],"In":[215],"(n=26),":[218],"patient":[220],"dose-limiting":[223],"toxicity":[224],"grade":[226],"(G)":[227],"fatigue":[229,270],"We":[233],"report":[234],"efficacy":[237],"for":[239],"40":[240],"dose-expansion":[244],"1.0-mg/kg":[245],"cohort.":[247],"duration":[249,357],"treatment":[251],"12":[253],"weeks":[254,383],"1.9\u201363.3).":[256],"Treatment-emergent":[257],"adverse":[258],"events":[259],"(TEAEs)":[260],"occurred":[261,283],"39":[263],"(98%)":[264],"patients,":[265,287],"most":[267,289],"frequent":[268,290],"being":[269,291],"(48%),":[271],"nausea":[272],"(45%),":[273],"anorexia":[274],"(38%),":[275,277],"thrombocytopenia":[276],"vomiting":[279],"(35%).":[280],"G3":[281],"TEAEs":[282,328],"18":[285],"(45%)":[286],"fatigue,":[292],"thrombocytopenia,":[293],"neutropenia":[295],"(10%":[296],"each);":[297],"G4":[299],"TEAE":[300],"dyspnea":[302],"reported.":[304],"Seven":[305],"died":[307],"due":[308],"malignant":[310],"neoplasm/disease":[311],"progression":[312],"(n=6)":[313],"respiratory":[315],"distress":[316],"(n=1);":[317],"none":[318],"related":[320],"Hepatotoxicity":[323],"observed,":[325],"including":[326],"G\u22652":[327],"hyperbilirubinemia":[330],"(18%),":[331],"increased":[332],"gamma-glutamyltransferase":[333],"(8%),":[334],"ascites":[335],"(5%),":[336],"veno-occlusive":[337],"liver":[338],"disease":[339],"(3%),":[340],"portal":[342],"hypertension":[343],"(3%).":[344],"Confirmed":[345],"objective":[346],"response":[347,359],"rate":[348,369],"25%":[350],"(10":[351,373],"partial":[352],"responses":[353],"[PR]),":[354],"median":[356,387],"4.2":[361],"months":[362],"(95%":[363],"CI:":[364],"2.6,":[365],"6.7).":[366],"Clinical":[367,418],"benefit":[368],"(CBR)":[370],"65%":[372],"PR":[374],"16":[376],"stable":[377],"disease)":[378],"CBR":[380],"lasting":[381],">12":[382],"43%.":[385],"The":[386,394],"progression-free":[388],"survival":[389],"3.5":[391],"months.":[392],"Conclusions:":[393],"MTD":[395],"not":[397],"reached":[398],"well":[402],"1.0":[405],"promising":[408],"observed.":[411],"Further":[412],"evaluation":[413],"ongoing.":[417],"trial":[419],"information:":[420],"NCT03639194":[421],".":[422]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":3}],"updated_date":"2026-10-15T10:00:46.086208","created_date":"2025-10-10T00:00:00"}